Antipsychotic Drug Risperdal, Prosecutors Seek $1 Billion From J&J in Marketing Probe
Posted May 13 2011 1:36pm
Alzheimer's Reading Room
Federal prosecutors are seeking roughly $1 billion to resolve a long-running probe into Johnson & Johnson's marketing of the antipsychotic drug Risperdal, according to people familiar with the matter.
Officials at J&J were surprised at the size of the sum that prosecutors are seeking, according to the people familiar with the matter. Prosecutors have been citing as a benchmark a $1.4 billion settlement that Eli Lilly & Co. reached in 2009 to resolve a probe into alleged improper marketing of its antipsychotic drug Zyprexa, according to one of the people. Lilly's alleged misconduct took place over a longer period of time, this person said.
From the Wall Street Journal, go here to read more.